You searched for "retinal"
Ocular Trauma Scores in paediatric open globe injuries
This is a retrospective case series of 71 open globe injuries in children of less than 18 years of age, with a minimum follow-up period of one year, between 1 September 1992 to 31 July 2011, from the Eye Department...
Tumour deposits following choroidal melanoma treatment
The authors present the unique case of retinoinvasive melanoma following treatment of choroidal melanoma with brachytherapy. Uveal melanoma, the commonest intraocular malignancy in adults, presents as a pigmented mass in the choroid, ciliary body, or iris. A 79-year-old Caucasian male...
Ranibizumab for the treatment of age-related macular degeneration
This multicentre randomised prospective open label study compared 0.5 versus 2mg of ranibizumab in patients with submacular retinal pigment epithelial (RPE) detachment due to age-related macular degeneration. Four treatment regimens were used for the two strengths either monthly for 12...
ICG TTT for retinoblastoma
Transpupillary thermotherapy (TTT) is a specific form of ocular TT using infrared radiation (diode laser). Indocyanine green (ICG) is also used to achieve the optimal phototherapy effect in eyes with minimal pigment. Twenty-one patients with 42 retinoblastomas in 30 eyes...
Screening for hydroxychloroquine retinopathy
The American Academy of Ophthalmology has updated the recommendations for screening for hydroxychloroquine retinopathy based on new scientific evidence that toxicity is not rare when hydroxychloroquine is used long-term, and that risk is dependent on the daily dose by weight....Line-up confirmed for Eye News Symposium!
We are delighted to confirm an excellent line-up of speakers and topics for the Eye News Symposium, taking place in Glasgow on Sunday 20 January.UK Eye Genetics Group (UK-EGG) 2024
by Mohammed Aslam, FY 3 Doctor, Calderdale and Huddersfield NHS Foundation Trust, UK. Founded in 2002, the UK EGG provides a hub to share knowledge on inherited eye disease and train the next generation of clinicians and scientists. This year’s...
Fingolimod: ocular adverse effects
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
Clinical presentation, management, and outcomes in posterior segment open globe injuries
This is a retrospective, non-comparative, interventional case study of patients presenting with scleral and corneoscleral wounds covering a five-year period. It reports the clinical presentation, management, and factors affecting the outcomes of posterior segment open globe injuries (OGI) in 2360...Pioneering eye device restores reading vision to blind eyes
A pivotal European clinical trial of a new electronic eye implant has seen remarkable results. The study, published in the New England Journal of Medicine, showed 84% of participants were able to read letters, numbers and words using prosthetic vision...Sense Medical and Canon: Getting ready for the OCT Pathway in Diabetic Eye Screening Surveillance Pathway webinar
Are you ready for the OCT pathway in DESP? OCT is set to be integrated into the English National Diabetic Eye Screening Surveillance Pathway, significantly enhancing the management of patients with mild diabetic maculopathy. This advancement allows patients to remain within a surveillance pathway overseen by retinal screening rather than being immediately referred to the Hospital Eye Service (HES). The webinar will be hosted by Professor Tunde Peto and Mrs Samantha Mann and will discuss the new OCT pathway, how OCT will change diabetic screening, how to interpret OCT images and how programmes can get ready for the change. Starts at 6pm UK time for 90 minutes
